Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF: Tricaprilin for Migraine Prevention
NCT04437199Phase 2Completed
- Sponsor
- Cerecin
- Start
- Dec 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tricaprilin in migraine, sponsored by Cerecin. Started Dec 2020; status: completed.
02
Drugs
tricaprilin
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04437199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437199.